Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Aberdare Ventures

1.Aberdare :: Vince Kim   (99%):
Vince Kim joined Aberdare in 2002. His principal area of investment focus is in medical devices and other novel healthcare technologies. Vince led the investment effort in VertiFlex, and contributed to the investment evaluations of Ample Medical, EnteroMedics and Posit Science. He is presently activ...
2.Aberdare :: Judy Stralka   (91%):
Judy Stralka has worked at Aberdare since its inception, having previously worked at Accel Partners for six years. Prior to joining Accel Partners in 1991, she was with McKinsey & Company in their San Francisco office. Judy received her BA from the University of Wisconsin, Oshkosh. Email Judy &c...
3.Aberdare :: Christina Fong   (80%):
Christina Fong came to Aberdare in May 1999 after working at Hellman & Friedman, a private San Francisco investment banking firm, for eight years. At Hellman & Friedman, she was responsible for the overall accounting functions of a $1 billion international investment fund. Prior to Hellman &...
4.Aberdare :: Dan Kisner   (70%):
Dan Kisner has a long history of leading venture-backed companies. Most recently, Dan served as President and CEO of Caliper Technologies. Dan led Caliper, a leader in microfluidic lab-on-a-chip technology, from a technology-focused start up to a publicly traded, commercially oriented organization. ...
5.Aberdare :: Naheed Ismaili   (70%):
Naheed Ismaili joined Aberdare Ventures from Bay City Capital, a leading life sciences merchant bank. At Bay City Capital, she evaluated numerous investment opportunities in biopharmaceuticals and assisted portfolio companies in their fundraising activities. She was also heavily involved in transfor...
6.Aberdare :: Terry Spraker   (70%):
Terry Spraker has over 25 years of experience as an entrepreneurial manager in medical device and equipment companies. Terry was VP/GM Global Coronary Business at Medtronic/ AVE. Prior to Medtronic, Terry was President and CEO of EP Technologies, a cardiac electrophysiology device company, through p...
7.Aberdare :: Our team   (65%):
Our experience building leading healthcare technology businesses over the years has taught us a thing or two about the primacy of people to the success of our companies and to that of our own organization. We are a small, yet deeply experienced and highly collaborative team. We understand that build...
8.Easton Capital Investment Group::Salmedix, Inc.   (61%):
Salmedix, Inc. Salmedix is a late stage biopharmaceutical company focusing on in-licensing and development of cancer products. The Company s lead product, SDX-105, is currently in Phase II/III clinical trials for non-Hodgkin s lymphoma. In addition, Salmedix has two drugs in Phase II clinical develo...
9.Aberdare :: Paul Klingenstein   (60%):
Paul Klingenstein has been a venture capital investor for most of his professional career. Beginning at Warburg, Pincus in the early 1980s, he joined Accel Partners in 1986 and helped, through the next decade, to build a leading venture capital firm. After a brief period as an advisor to the Rockefe...
10.Aberdare :: Jake Odden   (57%):
Jake Odden has spent his career working in a variety of investment, advisory and finance positions. Having gained his initial exposure to the investment business at the Vanguard Group, he then joined Goldman Sachs. At Goldman, he served as a financial analyst in the corporate finance group in New Yo...
11.Aberdare :: What we look for   (49%):
We invest in companies led by extraordinary people. We look for experienced management, ideally with established expertise in the targeted space, who work well together and who bring complementary skills to bear. We want to be part of building businesses that have the potential to be the leaders in ...
12.Aberdare :: Non healthcare companies   (49%):
Alibris Emeryville, CA | Marty Manley, President & CEO Alibris connects people who love books, music and movies to thousands of independent sellers around the world. Proprietary technology and advanced logistics allows the company to offer over 30 million used, new and hard-to-find titles to con...
13.Aberdare :: Who we are   (42%):
We are experienced venture investors and operators of healthcare technology companies. Our investment focus is driven by our years of experience growing biopharmaceutical product companies and therapeutic medical device companies. We invest in and work with a limited number of exceptional entreprene...
14.Aberdare :: Contact us   (41%):
One Embarcadero Center, Suite 4000 San Francisco, CA 94111 (415) 392-7442 T (415) 392-4264 F If we appear to be the right partner for your project, we encourage you to get an introduction to us from someone we know as this can often accelerate our initial review process. The introduction can be from...
15.Aberdare :: Contact us   (41%):
One Embarcadero Center, Suite 4000 San Francisco, CA 94111 (415) 392-7442 T (415) 392-4264 F Please note all directions are to the parking garage in One Embarcadero Center. The elevators to the 40th floor are one level above street level, so after exiting the garage elevator, you will have to take t...
16.Aberdare :: Directions from Marin County   (41%):
One Embarcadero Center, Suite 4000 San Francisco, CA 94111 (415) 392-7442 T (415) 392-4264 F Please note all directions are to the parking garage in One Embarcadero Center. The elevators to the 40th floor are one level above street level, so after exiting the garage elevator, you will have to take t...
17.Aberdare :: What we value   (32%):
We care a lot about the quality and integrity of management teams, co-investors, and strategic partners. We like to deal with not only the highest quality entrepreneurs, but with good people—we think they make better partners in the long run, and they attract colleagues and employees of equival...
18.Aberdare :: Directions from the South Bay   (32%):
One Embarcadero Center, Suite 4000 San Francisco, CA 94111 (415) 392-7442 T (415) 392-4264 F Please note all directions are to the parking garage in One Embarcadero Center. The elevators to the 40th floor are one level above street level, so after exiting the garage elevator, you will have to take t...
19.Vivo Ventures: News & Events   (29%):
News & Events Avera Pharmaceuticals Raises $48 million in Series C Venture Financing; New Board Members Named SAN DIEGO - August 4, 2004 -- Avera Pharmaceuticals, Inc., a privately held pharmaceutical development company focused on medicines for psychiatric and neurologic illnesses, today announ...
20.H.I.G. Capital: News   (28%):
FOR IMMEDIATE RELEASE Aaron Davidson Managing Director H.I.G. Ventures, LLC (305) 379-2322 Avera Pharmaceuticals Raises $48 million in Series C Venture Financing; New Board Members Named SAN DIEGO - August 4, 2004 - Avera Pharmaceuticals, Inc., a privately held pharmaceutical development company foc...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others